Gastroenteritis: Clinical Trials

5,697 trials for Gastroenteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2769 completed, 976 unknown, 686 recruiting, 517 terminated. 1483 Not applicable, 967 Phase 2, 677 Phase 3, 485 Phase 1, 407 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1483Completed 644, Unknown 319, Recruiting 193, Terminated 117, Not yet recruiting 89, Withdrawn 50, Active not recruiting 49, Enrolling by invitation 15, Suspended 7
Phase 2967Completed 479, Terminated 169, Recruiting 112, Unknown 89, Withdrawn 48, Active not recruiting 41, Not yet recruiting 21, Enrolling by invitation 5, Suspended 3
Phase 3677Completed 389, Terminated 101, Unknown 73, Recruiting 51, Active not recruiting 33, Withdrawn 19, Not yet recruiting 8, Enrolling by invitation 2, Suspended 1
Phase 1485Completed 275, Terminated 57, Unknown 48, Recruiting 42, Withdrawn 27, Not yet recruiting 21, Active not recruiting 11, Enrolling by invitation 3, Suspended 1
Phase 4407Completed 204, Unknown 63, Terminated 43, Recruiting 41, Not yet recruiting 25, Withdrawn 18, Active not recruiting 11, Enrolling by invitation 2
Early Phase 165Unknown 22, Completed 16, Recruiting 8, Not yet recruiting 7, Withdrawn 5, Terminated 3, Active not recruiting 2, Enrolling by invitation 2

Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Ranging Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Rectal Foam in Pediatric Patients Aged 5 to 17 Years With Active, Mild to Moderate Distal Ulcerative Colitis
High dose budesonide rectal foam, Low dose budesonide rectal foam, Matching placebo rectal foam - Ulcerative Colitis
Phase 4Not yet recruitingBausch Health Americas, Inc.1002029-06-012026-10-06
Methadone as an Alternative Treatment for Children Underdoing HSCT
PCA plus methadone (Experimental), PCA Alone (SOC) - Leukemia, Aplastic Anemia
Phase 3SuspendedUniversity of Texas Southwestern Medical Center602028-01-012025-10-23
ACT for Veterans With IBD and Mental Health Challenges
Acceptance and Commitment Therapy - Inflammatory Bowel Diseases, Crohn's Disease
Not applicableNot yet recruitingVA Office of Research and Development502028-01-012026-02-09
A Mindfulness-based Stress Reduction Program for IBD
Mindfulness based stress reduction, Active Control - Inflammatory Bowel Disease (Crohn&Amp;#39;s Disease and Ulcerative Colitis)
Not applicableNot yet recruitingNova Scotia Health Authority702027-09-012026-09-08
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Digital Mind Body Intervention mobile application - Crohn's Disease, Ulcerative Colitis
Not applicableNot yet recruitingMontefiore Medical Center402027-07-012026-09-14
Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
Adapted Physical Activity, Usual Care - Inflammatory Bowel Diseases (IBD), Fatigue
Not applicableNot yet recruitingUniversity Hospital, Grenoble1202027-06-012026-09-11
Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated Appendicitis
Piperacillin/Tazobactam, Ceftriaxone + Metronidazole - Appendicitis Perforated, Appendectomy, Laparoscopic
Phase 3Not yet recruitingMcMaster Children's Hospital1802027-04-012026-10-09
ASAPP Study - Topical 5-ASA as Prophylaxis for Pouchitis in Ulcerative Colitis Patients After Pelvic Pouch Surgery
5-ASA, Placebo - Ulcerative Colitis (UC), Pouchitis
Phase 4Not yet recruitingUniversity Hospital, Linkoeping1102027-04-012026-08-19
LMT503 First-in-human SAD, MAD, and FE Study
LMT503, Placebo - Inflammatory Bowel Disease, Colitis, Ulcerative
Phase 1Not yet recruitingLmito Therapeutics Inc.722027-03-012026-09-01
Povidone-iodine Irrigation for Prevention of Intra-abdominal Abscess in Pediatric Perforated Appendicitis: a Multi-center Stepped Wedge Cluster Randomized Study
Irrigation with PVI, Usual care - Acute, Perforated Appendicitis
Phase 4Not yet recruitingThe University of Texas Health Science Center, Houston17502027-03-012025-02-10
Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).
TRA16, Placebo - Enteric Hyperoxaluria
Phase 2Not yet recruitingWuhan Kangfude Urolithiasis Research Institute Co., Ltd.302027-03-012026-10-13
Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis
Nitazoxanide (NTZ) - Ulcerative Colitis (UC)
Phase 2 / Phase 3Not yet recruitingTanta University442027-01-012026-09-15
Perforated Appendicitis and Postoperative Antibiotics Pilot Trial
Postoperative antibiotico-prophylaxis, No postoperative antibiotics - Perforated Appendicitis
Not applicableNot yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1002027-01-012026-09-17
Safety and Efficacy of a STOPping Strategy Versus Classical Maintenance Dose of JAK Inhibitors in Deep Remission Patients With Ulcerative Colitis
treatment withdrawal - Ulcerative Colitis in Remission
Phase 4Not yet recruitingAssistance Publique Hopitaux De Marseille2242027-01-012026-07-22
Biophysical Assessments of Acupuncture Points in Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD)
Not yet recruitingBrigham and Women's Hospital1002027-01-012026-10-20
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
MTB-targeted phage therapy - Pouchitis, UC - Ulcerative Colitis
Early Phase 1Not yet recruitingJinling Hospital, China122027-01-012026-10-22
Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis
ATTO-1091, Placebo - Ulcerative Colitis (UC)
Phase 1Not yet recruitingAttovia Therapeutics Inc962026-12-142026-09-15
Pilot Study of Salivary Bile Acids and Pepsin as Predictive Biomarkers of Reflux Disease After Sleeve Gastrectomy
Reflux Disease, Gastro-Esophageal, Sleeve Gastrectomy
Not yet recruitingHospital de Mataró602026-12-012026-05-26
Music and VR Effects on Pain, Anxiety, and Fear During Oral Mucositis Care in Leukaemic Children
Music intervention, Virtual reality - Anxiety, Pain
Not applicableNot yet recruitingEge University452026-12-012026-05-19
Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD)
Magnetic Flexible Endoscope (MFE) - Inflammatory Bowel Disease (IBD), Colonoscopy
Not applicableNot yet recruitingVanderbilt University Medical Center62026-12-012026-08-20

Showing 20 of 5697. Sign in to see all of them.

Narrower conditions

Crohn Disease (1947)  ·  Colitis, Ulcerative (1792)  ·  Inflammatory Bowel Diseases (1547)  ·  Appendicitis (400)  ·  Eosinophilic Esophagitis (234)  ·  Enterocolitis, Necrotizing (222)  ·  Mucositis (208)  ·  Colitis (127)  ·  Diverticulitis (100)  ·  Diarrhea (96)  ·  Gastritis (91)  ·  Esophagitis (88)  ·  Colorectal Neoplasms (87)  ·  Arthritis, Rheumatoid (86)

Broader conditions

Digestive System Diseases (5646)  ·  Gastrointestinal Diseases (5615)  ·  Intestinal Diseases (4834)  ·  Inflammatory Bowel Diseases (2266)  ·  Colonic Diseases (2046)  ·  Colitis (1769)  ·  Pathological Conditions, Signs and Symptoms (887)  ·  Infections (726)  ·  Immune System Diseases (449)  ·  Pathologic Processes (449)  ·  Cecal Diseases (400)  ·  Intraabdominal Infections (396)  ·  Esophageal Diseases (378)  ·  Signs and Symptoms (373)

Interventions

Infliximab (147)  ·  Mesalamine (117)  ·  Adalimumab (109)  ·  vedolizumab (100)  ·  Fecal Microbiota Transplantation (85)  ·  Ustekinumab (66)  ·  Metronidazole (53)  ·  Appendectomy (48)  ·  Azathioprine (47)  ·  Blood Specimen Collection (47)  ·  Budesonide (43)  ·  Colonoscopy (39)  ·  Certolizumab Pegol (35)  ·  Probiotics (35)  ·  Endoscopy (33)

Sponsors

Takeda (96)  ·  AbbVie (74)  ·  Assiut University (69)  ·  Mayo Clinic (65)  ·  Pfizer (60)  ·  GlaxoSmithKline (57)  ·  Janssen Research & Development, LLC (46)  ·  Assistance Publique - Hôpitaux de Paris (41)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (41)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (35)  ·  AstraZeneca (34)  ·  Children's Hospital Medical Center, Cincinnati (34)  ·  Central Hospital, Nancy, France (30)  ·  Ferring Pharmaceuticals (30)  ·  Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (30)

Countries

United States (1798)  ·  Canada (612)  ·  France (603)  ·  China (506)  ·  United Kingdom (496)  ·  Italy (485)  ·  Germany (475)  ·  Belgium (390)  ·  Israel (389)  ·  Poland (386)  ·  Spain (368)  ·  Netherlands (362)  ·  South Korea (291)  ·  Hungary (275)  ·  Australia (271)

Top investigators

Arie Levine, MD (10)

Results publications

PMID 40243391, PMID 40357993, PMID 40013523, PMID 29380251, PMID 32445184, PMID 26893500, PMID 35648151, PMID 36124702, PMID 37368103, PMID 29850873, PMID 30476584, PMID 30739254, PMID 31077827, PMID 31599001, PMID 32816215, PMID 33684552, PMID 35792493, PMID 36342120, PMID 36526796, PMID 36931693, PMID 38425446, PMID 39778975, PMID 19735233, PMID 20195905, PMID 25996351, PMID 32635680, PMID 32766762, PMID 32870265, PMID 32964215, PMID 33127596, PMID 33324993, PMID 33513294, PMID 34614208, PMID 35380664, PMID 35380740, PMID 36150926, PMID 36208720, PMID 36336750, PMID 37224198, PMID 37402275, PMID 37560161, PMID 38096402, PMID 38310565, PMID 38778549, PMID 41264726, PMID 41763462, PMID 42248437, PMID 16339095, PMID 19596014, PMID 21129076

NIH funding

2023 (55), 2017 (44), 2016 (32), 2014 (30), 2025 (29), 2018 (28), 2015 (26), 2019 (25), 2009 (14), 2008 (11), 2004 (6), 2005 (4), U54AI117804 (4), UL1TR001082 (4), U10HD021364 (3)